187 related articles for article (PubMed ID: 33378951)
1. Anti-inflammatory potential of myristic acid and palmitic acid synergism against systemic candidiasis in Danio rerio (Zebrafish).
Prasath KG; Alexpandi R; Parasuraman R; Pavithra M; Ravi AV; Pandian SK
Biomed Pharmacother; 2021 Jan; 133():111043. PubMed ID: 33378951
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis uncovers the modulation of ergosterol, sphingolipid and oxidative stress pathway by myristic acid impeding biofilm and virulence in Candida albicans.
Prasath KG; Sethupathy S; Pandian SK
J Proteomics; 2019 Sep; 208():103503. PubMed ID: 31454558
[TBL] [Abstract][Full Text] [Related]
3. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
4. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.
Cui J; Ren B; Tong Y; Dai H; Zhang L
Virulence; 2015; 6(4):362-71. PubMed ID: 26048362
[TBL] [Abstract][Full Text] [Related]
5.
Romo JA; Pierce CG; Esqueda M; Hung CY; Saville SP; Lopez-Ribot JL
Front Cell Infect Microbiol; 2018; 8():227. PubMed ID: 30042929
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Zhang M; Yan H; Lu M; Wang D; Sun S
Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
[TBL] [Abstract][Full Text] [Related]
7. Candida albicans Infection Model in Zebrafish (Danio rerio) for Screening Anticandidal Drugs.
Kulatunga DCM; Dananjaya SHS; Nikapitiya C; Kim CH; Lee J; De Zoysa M
Mycopathologia; 2019 Oct; 184(5):559-572. PubMed ID: 31473909
[TBL] [Abstract][Full Text] [Related]
8. Repurposing of Ribavirin as an Adjunct Therapy against Invasive
Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory Effect of Morin Against
Abirami G; Alexpandi R; Durgadevi R; Kannappan A; Veera Ravi A
Front Microbiol; 2020; 11():561298. PubMed ID: 33193145
[No Abstract] [Full Text] [Related]
10. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
11. Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence.
Sun W; Wang D; Yu C; Huang X; Li X; Sun S
Int J Antimicrob Agents; 2017 Sep; 50(3):399-405. PubMed ID: 28673609
[TBL] [Abstract][Full Text] [Related]
12. Palmitic Acid Inhibits the Virulence Factors of
Prasath KG; Tharani H; Kumar MS; Pandian SK
Front Microbiol; 2020; 11():864. PubMed ID: 32457728
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase.
Rabelo VW; Viegas DJ; Tucci EMN; Romeiro NC; Abreu PA
J Steroid Biochem Mol Biol; 2019 Jan; 185():189-199. PubMed ID: 30193921
[TBL] [Abstract][Full Text] [Related]
14. Phloretin inhibited the pathogenicity and virulence factors against
Liu N; Zhang N; Zhang S; Zhang L; Liu Q
Bioengineered; 2021 Dec; 12(1):2420-2431. PubMed ID: 34167447
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.
Siopi M; Tsala M; Siafakas N; Zerva L; Meletiadis J
J Clin Microbiol; 2015 Nov; 53(11):3654-9. PubMed ID: 26338855
[TBL] [Abstract][Full Text] [Related]
16. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal.
Subramanya SH; Baral BP; Sharan NK; Nayak N; Metok Y; Sathian B; Bairy I; Gokhale S
BMC Res Notes; 2017 Nov; 10(1):543. PubMed ID: 29096684
[TBL] [Abstract][Full Text] [Related]
18. SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
Scorneaux B; Angulo D; Borroto-Esoda K; Ghannoum M; Peel M; Wring S
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069658
[TBL] [Abstract][Full Text] [Related]
19. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
20. Insights into Candida tropicalis nosocomial infections and virulence factors.
Negri M; Silva S; Henriques M; Oliveira R
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1399-412. PubMed ID: 22037823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
